500: Is this Tamiflu 2.0?
499: What is the Clinical Effectiveness of PCC in Factor Xa Inhibitor-Related Intracranial Hemorrhage?
498: NIH Guidelines on Therapeutic Options for COVID-19
497: Can the Tisdale Risk Score be used to identify ICU patients at risk of QTc prolongation?
496: Can alteplase be used to treat COVID-19 patients with thrombotic disseminated intravascular coagulation?
495: AHA and ACC Presidents offer advice on QTc interaction between hydroxychloroquine and azithromycin
494: What to use for acute asthma exacerbation if you run out of MDIs?
493: Can hydromorphone infusion be used in ventilated ICU patients?
492: Do unused and unopened medications that have been in COVID-19 patient rooms need to be discarded?
491: Pharmacy-related COVID-19 updates
490: Which vasopressor should be discontinued first?
- « Previous Page
- 1
- …
- 45
- 46
- 47
- 48
- 49
- …
- 88
- Next Page »